WIZP

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 12/27/2017
Contact Info
  • 5b Hanagar Street
  • Hod Hasharon 4527708
  • Israel

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2017 10-Q
CIK 0001218683
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 1999
Employees Not Available
Company Officers/Contacts
Noam Danenberg COO
Or Eisenberg CFO, Acting CEO
Company Directors
Ron Mayron Chairman
Dr. Franck Amouyal
Michael Belkin
Yossi Keret
Joseph Zarewsky
Company Notes
  • Formerly=OphthaliX Inc. until 11-2017
  • Formerly=Denali Concrete Management, Inc. until 2-2012
Service Providers
Accounting/Auditing Firm
Kost Forer Gabbay & Kasierer
3 Aminadav St.
Tel-Aviv, 67067
Israel

Legal Counsel
Sichenzia Ross Ference Kesner LLP
1185 Avenue of the Americas
37th Floor
New York, NY, 10036
United States

Investor Relations Firm
Not Available
WIZP Security Details
Share Structure
Market Value1 $14,617,751 a/o Jan 23, 2018
Authorized Shares 500,000,000 a/o Jan 02, 2018
Outstanding Shares 104,412,510 a/o Jan 02, 2018
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders
Shareholders of Record 15 a/o Mar 02, 2016
Short Selling Data
Short Interest 700 (100%)
Oct 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security